Publications | CDI Pathogenesis and Therapy - Wang Lab at Biomedical Sciences of HCOM

2023

Wang, Shaohua. 2023. Bacterial strain useful for treatment of age-related conditions, issued 2023.

2022

Wang, Shaohua. 2022. “Protection of Cognitive Decline and Alzheimer’s Disease Progression by a Human Origin‐probiotic Biotherapy.”

2021

Wang, Shaohua. 2021. “A Novel Probiotics Therapy for Aging-Related Leaky Gut and Inflammation.”

Wang, Shaohua. 2021. “Metformin Reduces Clostridium Difficile infection.”

Wang, Shaohua. 2021. “Microbiota Induces Aging-Related Leaky Gut and Inflammation by Dampening Mucin Barriers and Butyrate-FFAR2/3 Signaling.”

2020

Wang, Shaohua. 2020. “Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis.”

Wang, Shaohua. 2020. “Gut Mycobiome and Its Interaction With Diet, Gut Bacteria and Alzheimer’s Disease Markers in Subjects With Mild Cognitive Impairment: A Pilot Study.”

Wang, Shaohua. 2020. “Lipoteichoic Acid from the Cell Wall of a Heat Killed Lactobacillus Paracasei D3-5 Ameliorates Aging-Related Leaky Gut, Inflammation and Improves Physical and Cognitive.”

Wang, Shaohua. 2020. “A Human-Origin Probiotic Cocktail Ameliorates Aging-Related Leaky Gut and Inflammation via Modulating the Microbiota/Taurine/Tight Junction Axis.”

2019

Wang, Shaohua. 2019. “A Human‐origin Probiotics Cocktail Exhibit Cardio‐protective Effects Independent of GLP‐1 Receptor Signaling.”